GMI

Review provides evidence that mitochondrial mechanisms for statin-induced muscle adverse effects (AEs) have implications to non-muscle AEs ranging from thyroid dysfunction to neuropathy to cognitive loss.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *